ARSENAULT KAITLYN
SEC insider (Form 3/4/5 filer). CIK 0001877242. Chief Financial Officer at Skye Bioscience, Inc. (SKYE). 5 reported Form 4/5 transactions since Sep 2024; latest on Feb 6, 2026. Located in SAN DIEGO, CA.
Companies ARSENAULT KAITLYN has filed insider reports for
- Skye Bioscience, Inc. (SKYE): Officer, Chief Financial Officer
ARSENAULT KAITLYN
CIK: 0001877242
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Skye Bioscience, Inc.
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Feb 6, 2026SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
125K shares- - Feb 24, 2025SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
150K shares- - Nov 18, 2024SKYE
Skye Bioscience, Inc.
SaleDirect43K shares at avg. $4.99$215K - Nov 15, 2024SKYE
Skye Bioscience, Inc.
SaleDirect190 shares at avg. $5.55$1K - Oct 28, 2024SKYE
Skye Bioscience, Inc.
AwardDirectStock Option (Right to Buy)
125K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 6, 2026 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 125,000 | - | - | Direct |
| Feb 24, 2025 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 150,000 | - | - | Direct |
| Nov 18, 2024 | SKYE Skye Bioscience, Inc. | Sale | 43,026 | $4.99 | $214,700 | Direct |
| Nov 15, 2024 | SKYE Skye Bioscience, Inc. | Sale | 190 | $5.55 | $1,055 | Direct |
| Oct 28, 2024 | SKYE Skye Bioscience, Inc. | Award Stock Option (Right to Buy) | 125,000 | - | - | Direct |
1-5 of 5 transactions